Specify a stock or a cryptocurrency in the search bar to get a summary
Sopharma AD
SPHSopharma AD produces, distributes, and exports pharmaceutical products in Europe, Bulgaria, and internationally. The company operates through Production of Pharmaceutical Products; Distribution of Pharmaceutical Products (Goods); and Others. It offers Carsil to treat liver disease; Tempalgin and Analgin, a painkiller; Tabex, drug used for smoking secession; Tribestan, drug used for stimulation of the male reproductive system; Broncholytin, which is used to suppress cough; Nivalin, used for diseases of the peripheral nervous system; Methylprednisolon, for severe allergies and life-threatening conditions; Vitamin C; Valeriana, used to reduce the stress; and medical devices, such as gauzes, compresses, and dressing. The company also provides food supplements; medicinal cosmetics, including plasters, bandages, and sanitary-hygiene products focused; and prescription medicines, on the counter products, and veterinary products. In addition, the company distributes pharmaceuticals, medical supplies, sanitary materials, vitamins, food supplements, and cosmetics; and provides contract manufacturing services; packaging services; and product development services. Further, it is involved in trading of food supplements; secondary packaging services for pharmaceutical products and real estate leases; trades, transports, and packages radioactive materials and nuclear equipment for medicinal use, household electronics, and electrical equipment; purchases, grows, produces, and trades in herbs and medicinal plant; and provision of public opinion research services. Additionally, the company engages in the offline and online retail trade of medicinal products and medical equipment; production of non-medicinal, and other products; and franchising, know-how, and rental of properties, as well as in trading, consulting, and other activities. Sopharma AD was founded in 1933 and is headquartered in Sofia, Bulgaria. Address: 16 Iliensko shosse street, Sofia, Bulgaria, 1220
Analytics
WallStreet Target Price
17.15 PLNP/E ratio
12.3529Dividend Yield
19.77 %Current Year
Last Year
Current Quarter
Last Quarter
Current Year
Last Year
Current Quarter
Last Quarter
Key Figures SPH
Dividend Analytics SPH
Dividend growth over 5 years
848 %Continuous growth
2 yearsPayout Ratio 5 years average
105 %Dividend History SPH
Stock Valuation SPH
Financials SPH
Results | 2019 | Dynamics |